biotech
Bio-AnalystSupplement research
person

Glycine

Blood lipids

Studies with an unspecified organism reported a change with no confirmed comparison group in hyperlipidemia.

Single-ingredient studies · Includes patient groups · comparator not confirmed

Publications for this result: 1

Other outcomes and study details

Distinct publications linked to this topic: 1

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.

What has been studied?

Distinct human comparison papers: 0

  • hyperlipidemia

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      • Review
      • Review
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Study subject not identified
      • Timepoint: Unspecified
      • Study comparison: Review-level summary claim for glycine supplementation; no comparator specified
Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Glucose and metabolic health

    Related papers 6 · human comparison papers 1

    View results
    • plasma glucose area response · Improvement reported
    • diabetes · Some studies included patients or people with a deficiency · Comparison details unconfirmed

    More outcome groups: 3

  • Blood pressure and vascular health

    Related papers 3 · comparison findings need further review

    View results
    • BP differences · Comparison details unconfirmed
    • hypertension · Some studies included patients or people with a deficiency · Comparison details unconfirmed

    More outcome groups: 1

  • Immune and respiratory health

    Related papers 2 · comparison findings need further review

    View results
    • development of chronic inflammation · Interpretation held
  • Blood lipids

    Related papers 1 · comparison findings need further review

    View selected result
  • Cognition

    Related papers 1 · comparison findings need further review

    View results
    • cognitive functioning · Interpretation held
  • Digestion and gut health

    Related papers 1 · comparison findings need further review

    View results
    • disease activity index · Interpretation held
  • Sleep

    Related papers 1 · comparison findings need further review

    View results
    • sleep · Comparison details unconfirmed
  • Stress and mood

    Related papers 1 · comparison findings need further review

    View results
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 32.2 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 93

Papers linked to this topic 1 · distinct papers 1 · comparison findings need further review · papers needing additional review 0

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • hyperlipidemia: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Glucose and metabolic health

What the research found

plasma glucose area response

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

diabetes

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

obesity

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

insulin response

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

weight gain

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood pressure and vascular health

What the research found

BP differences

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

hypertension

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

systolic blood pressure

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Immune and respiratory health

What the research found

development of chronic inflammation

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood lipids

What the research found

hyperlipidemia

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cognition

What the research found

cognitive functioning

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Digestion and gut health

What the research found

disease activity index

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sleep

What the research found

sleep

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
0
Findings from individual and combined use, plus reviewed cautions
Key precautions
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 1 combination findings and 0 findings that outperformed an ingredient alone.
These findings were reported in studies. They do not predict an individual's experience.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

NACIn a randomized clinical trial of older adults, GlyNAC (a combination of glycine and NAC) supplementation for 16 weeks improved glutathione deficiency, oxidative stress, and mitochondrial dysfunction compared to placebo.